Praetorian Wealth Management, Inc. My Md Pharmaceuticals, Inc. Transaction History

Praetorian Wealth Management, Inc.

  • $398 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 11, 2023
BUY
$0.47 - $1.87 $82,250 - $327,250
175,000 Added 700.0%
200,000 $118,000
Q4 2022

Jan 11, 2023
BUY
$0.92 - $96.0 $9,200 - $960,000
10,000 Added 66.67%
25,000 $0
Q2 2022

Jul 14, 2022
BUY
$2.0 - $4.78 $30,000 - $71,700
15,000 New
15,000 $32,000

Others Institutions Holding MYMD

# of Institutions
2
Shares Held
30.2K
Call Options Held
0
Put Options Held
0
View Full List

About MyMD Pharmaceuticals, Inc.

MYMD Quotes by TradingView
  • Ticker MYMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,470,000
  • Market Cap $67.5M
  • Description
  • MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...
More about MYMD
Track This Portfolio

Track Praetorian Wealth Management, Inc. Portfolio

Follow Praetorian Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Praetorian Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Praetorian Wealth Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email